Press releases

2025-02-19 08:00 Prolight receives second Notice of Intention to Grant from European Patent Office for Psyros™ technology

2025-02-18 08:00 Prolight receives Notice of Intention to Grant for core Psyros™ patent

2024-12-17 11:00 Prolight Diagnostics publishes investor letter for December 2024

2024-12-09 08:00 Prolight strengthens IP portfolio by additional patent application

2024-12-03 13:41 EMERGERS VALUE PROLIGHT DIAGNOSTICS AT 730 MSEK (0,9- 1,0 SEK PER SHARE)

2024-12-03 08:00 Prolight achieves significant milestone with arrival of first Psyros™ commercial prototype instruments

2024-11-29 08:10 The nomination committee appointed for the Annual General Meeting 2025. Regulatory

2024-11-27 08:00 Prolight Diagnostics publishes quarterly report Q3, 2024 Regulatory MAR

2024-10-21 15:10 Warrants of series TO7 were exercised to approximately 96.4 percent and Prolight Diagnostics receives approximately SEK 12.6 million Regulatory MAR

2024-10-15 08:00 Last day of trading with warrants of series TO7 in Prolight Diagnostics is today, October 15, 2024 Regulatory

Subscribe